| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Did you know that our body produces Cannaboid (CBD)? Yes, that’s right! Our body has something called an Endocannabinoid system (ECS) which is also known as “the survival system”. Our ECS regulates everything from rest and relaxation to digestion to inflammation to organ and muscle performance, basically everything in our body that is connected to our brain and central nervous system. The ECS produces CBD which stimulates responses to naturally reduce aches, pains, improve mobility, flexibility, even moods, headaches, and sleep. If this is true, then you might be asking yourself, “Is my ECS even working?” Or maybe you are wondering, “If my body produces CBD why do some tell me this is a controlled substance and I could lose my job if I am using a CBD supplement?”[CR-LF][CR-LF]According to Quest Diagnostics Director of Science and Technology, Barry Sample, "If the product contains only CBD and has had the THC removed, then an individual being tested would not be expected to test positive for marijuana or marijuana metabolite." In other words, drug tests screen for THC, not CBD.
A federal court has given preliminary approval to a class action lawsuit against Quest Diagnostics field on behalf of individuals whose HIV testing data was exposed in a 2016 data breach.[CR-LF][CR-LF]The US District Court for the District of New Jersey approved on October 25, 2019, a $195,000 settlement between the plaintiffs and Quest under which lawsuit class members who are able to show they incurred monetary damages due to the breach can collect $250 each and members whose HIV test results were exposed can collect $75 each.
A federal court granted approval Oct. 25 to Quest Diagnostics to settle a class-action lawsuit that stemmed from a 2016 data breach for $195,000, according to GovInfoSecurity.com.[CR-LF][CR-LF]In November 2016, around 34,000 individuals may have had their protected health information exposed after an unauthorized third party gained access to the lab testing company's web application.
Welcome to the "Lessons from the C-suite" series, featuring Advisory Board President Eric Larsen's conversations with the most influential leaders in health care.[CR-LF][CR-LF]In this edition, Steve Rusckowski, chair, president, and CEO of Quest Diagnostics, talks about how diagnostic information services can inflect the country's $3.6 trillion in health care costs, the unexpected upside of the Theranos misadventure, and how Quest is thinking about the drawbacks—and benefits—of the landscape-changing regulatory shift known as PAMA.
Over the past year, I’ve spent time outside of the office helping two uncles, both of whom are struggling with medical conditions exacerbated by their advanced ages. This has been neither a burden nor an obligation; I consider it a privilege to be able to help provide loving care for the two of them.[CR-LF][CR-LF]According to a recent survey by Quest Diagnostics, 2 in 5 older Americans with chronic conditions reported that they do not tell their doctor about loneliness, isolation, transportation barriers and other factors that influence health, with many admitting they "struggle to stay on top of my health issues and need more support."